Dr. Samuel Mcelwee
Critical Care Medicine (Critical Care Medicine (Internal Medicine) Physician)
- Medicare participating
At a glance
- Medical school
- University of Alabama School of Medicine (2010)
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 232
Licensed in Alabama since 2011, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Medical school: University of Alabama School of Medicine
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Critical Care Medicine (Internal Medicine) Physician primary
AL license 31232 (first issued 2011; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Alabama Hospital Birmingham, AL
- Medical West, An Affiliate of Uab Health System Bessemer, AL
Medical groups
- University of Alabama Health Services Foundation, PC (2,814 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 232
- Services billed
- 741
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 217 | 59 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 129 | 56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 127 | 127 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 76 | 33 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 67 | 38 |
| Injection, perflutren lipid microspheres, per ml | 36 | 18 |
| Heart muscle strain imaging | 33 | 33 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 29 | 28 |
| Hospital discharge day management, 30 minutes or less | 28 | 28 |
| Ultrasound of heart with probe in esophagus, with report | 17 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 2 companies reported 5 payments worth $690 in total to this clinician.
| Boston Scientific Corporation | $423 |
|---|---|
| Abiomed | $267 |
| Food and Beverage | $690 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $46,090 in research payments for these studies, mostly to the institutions running them.
- The PEERLESS II Study
Stryker Corporation · Completed · NCT06055920 - Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
Boston Scientific Corporation · Active, not recruiting · NCT04790370
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.